Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-23-006524

Head of Pharm Ops and Tech gave up 233 shares (to pay taxes)

  • Head of Pharm Ops and Tech acquired 480 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Murphy Nicole Head of Pharm Ops and Tech 2023-02-17 Option exercise +480 5,579.29 D: show line 1 in the form
Murphy Nicole Head of Pharm Ops and Tech 2023-02-17 Shares withheld for taxes −233 $278.38 $64,863 5,099.29 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Murphy Nicole Head of Pharm Ops and Tech 2023-02-17 Option exercise · Restricted Stock Unit −480 1,334 D: show line 3 in the form
Murphy Nicole Head of Pharm Ops and Tech 2023-02-17 Other disposition · Restricted Stock Unit −426 908 D: show line 4 in the form
Loading xslF345X03/form4.xml…